Ocular Therapeutix (NASDAQ:OCUL) Upgraded at StockNews.com

Ocular Therapeutix (NASDAQ:OCUL – Get Rating) was upgraded by investment analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. A number of other research analysts have also recently weighed in on the company. Robert W. Baird lifted their price objective on Ocular Therapeutix from $10.00 […]

Related Keywords

Dekabank Deutsche Girozentrale ,Robertw Baird ,Amarpreets Sawhney ,Ocular Therapeutix Inc ,Archford Capital Strategies ,Ahrens Investment Partners ,Mackenzie Financial Corp ,Ocular Therapeutix ,Get Rating ,Financial Corp ,Bank Deutsche Girozentrale ,Investment Partners ,Farhad Khosravi ,Ocular Therapeutix Daily ,Nasdaq Ocul ,Hocul ,Medical ,Upgrade ,Stocknews Com ,